Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-01-17
1997-06-17
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514330, 514277, 514247, 514269, 514315, 514432, 514449, 514 20, 514467, 514634, 514317, A61K 31535, A61K 3800, A61K 31155, A61K 3136
Patent
active
056397658
ABSTRACT:
This invention herein relates to a method of inhibiting bone resorption by administering a therapeutically effective amount of a compound having the following formula ##STR1## or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 4879313 (1989-11-01), Tjoeng et al.
patent: 4952562 (1990-08-01), Klein et al.
patent: 5260277 (1993-11-01), McKenzie
patent: 5403836 (1995-04-01), Blackburn et al.
Fok et al. "Aminopeptidase resistant Arg-Gly-Asp analogs are stable in plasma and inhibit platelet aggregation." Int. J. Peptide Protein Res., 38, 124-130 (1991).
Greenspoon et al. "Structural Analysis of Integrin-Mediated Cell Functions by Novel Nonpeptide Surrogates of the Arg-Gly-Asp Sequence." Biochemistry, 32, 1001-1008 (1993).
McDowell et al. "From Peptide to Non-Peptide. The Elucidation of a Bioactive Conformation of the Arg-Gly-Asp Acid Recognition Sequence." J. Am. Chem. Soc., 116, 5069-5076 (1994).
Criares Theodore J.
G. D. Searle & Co.
Kovacevic Cynthia S.
Williams Roger A.
LandOfFree
Guanidinoalkyl glycine .beta.-amino acids useful for inhibiting does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Guanidinoalkyl glycine .beta.-amino acids useful for inhibiting , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Guanidinoalkyl glycine .beta.-amino acids useful for inhibiting will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2158079